New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide ...

An AI test boosts cure chances for prostate cancer by predicting who benefits from abiraterone, reducing side effects and ...

Detailed data will be presented at a future medical meeting and submitted for regulatory review later this year.

AI could eliminate the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers ...

The test, developed by Artera, uses AI to pick up features invisible to the human eye on images of tumour samples.

Presentation highlights deep and durable responses and radiographic resolution of bone metastases in patients with advanced prostate cancer Final clinical data demonstrate an 87% overall response rate ...

Reinforcing its commitment to pioneering advanced cancer care, Sarvodaya Hospital, Faridabad, Delhi NCR is proud to announce ...

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive mHSPC: Basel Tuesday, June 3, 2025, 12:00 Hrs [IST] ...

Novartis said Pluvicto demonstrated positive result in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.

Former President Joe Biden updated reporters about his cancer treatment in Delaware on Friday after delivering remarks at a ...